Schizophrenia is a severe mental disorder affecting ~1% of the world population, with heritability of up to 80%. To identify new common genetic risk factors, we performed a genomewide association study (GWAS) in the Han Chinese population. The discovery sample set consisted of 3,750 individuals with schizophrenia and 6,468 healthy controls (1,578 cases and 1,592 controls from northern Han Chinese, 1,238 cases and 2,856 controls from central Han Chinese, and 934 cases and 2,020 controls from the southern Han Chinese). We further analyzed the strongest association signals in an additional independent cohort of 4,383 cases and 4,539 controls from the Han Chinese population. Meta-analysis identified common SNPs that associated with schizophrenia with genome-wide significance on 8p12 (rs16887244, P = 1.27 × 10 −10 ) and 1q24.2 (rs10489202, P = 9.50 × 10 −9 ). Our findings provide new insights into the pathogenesis of schizophrenia.
and 1,592 healthy controls from the northern Han Chinese population (Beijing and Shandong provinces), (ii) 1,238 subjects with schizophrenia and 2,856 healthy controls from the central Han Chinese population (Shanghai and Anhui provinces), and (iii) 934 subjects with schizophrenia and 2,020 healthy controls from the southern Han Chinese population (Guangdong and Guangxi provinces). Sample descriptions and characteristics can be found in Online Methods and Supplementary Table 1 . We carried out a meta-analysis using the PCA-adjusted association results of the three cohorts (see Online Methods and Supplementary Fig. 1 ). For all reported SNPs, the observed P values were identical when the fixed-and randomeffects models were used for meta-analysis, and no heterogeneity was found among the three cohorts (Supplementary Table 2 ). Although no SNP reached genome-wide significance (P < 5.0 × 10 −8 ), four SNPs on 8p12 (rs1488935, P GWAS−meta = 2.81 × 10 −6 ) and 1q24.2 (rs10489202, P GWAS−meta = 2.65 × 10 −6 ; rs1060041, P GWAS−meta = 4.11 × 10 −6 ; rs11586522, P GWAS−meta = 1.53 × 10 −6 ) showed strong association (P GWAS−meta < 5.0 × 10 −6 ) ( Table 1 , Supplementary Fig. 2 and Supplementary Table 2) . We examined the top SNPs in these regions (three SNPs on 1q24.2 and two on 8p12) for association in an independent cohort of 4,383 subjects with schizophrenia and 4,539 healthy controls, which, together with the discovery sample set, we defined as the BIOX sample. We successfully replicated the association findings for 8p12 and 1q24.2, and the associations in the BIOX sample reached genome-wide significance (8p12: rs16887244, P BIOX−meta = 1.27 × 10 −10 , G allele odds ratio (OR) = 0.84, 95% confidence interval (CI) = 0.79-0.88; rs1488935, P BIOX−meta = 5.06 × 10 −9 , T allele OR = 0.85, 95% CI = 0.81-0.90; 1q24.2: rs10489202, P BIOX−meta = 9.50 × 10 −9 , A allele OR = 1.23, 95% CI = 1.15-1.32) ( Table 1) . To search for additional associations of common variants, we also carried out imputation analysis in the selected regions (Fig. 1) .
We further validated our top association signals by obtaining results from the SGENE-plus project, a large-scale genome-wide association study of schizophrenia that aims to identify genetic variants associated with the disease and to study their impact on phenotype and their interaction with environmental factors contributing to pathogenesis. This GWAS included 3,830 subjects with schizophrenia and 14,724 controls of European ancestry. Both rs16887244 (P SGENE−plus = 0.026, G allele OR = 0.92, 95% CI = 0.85-0.99) and rs1488935 (P SGENE−plus = 0.027, T allele OR = 0.92, 95% CI = 0.85-0.99) showed nominal association with schizophrenia in the population of European ancestry, and the direction of the effect was consistent with our findings (Supplementary Tables 2 and 3) . The effect size for rs10489202 (A allele OR = 1.01, 95% CI = 0.94-1.09) was small in the SGENE-plus data (Supplementary Table 3) . A statistical power comparison between the two data sets was also carried out (Supplementary Table 4) .
On 8p12, both the rs16887244 and rs1488935 SNPs reached genomewide significance in the combined analysis ( Fig. 1a and Table 1) . Controlling for rs16887244, conditional logistic regression analysis revealed that there were no additional association signals (Supplementary Table 5 ). The rs16887244 SNP is located in intron 1 of LSM1 (MIM: 607281), and rs1488935 is located in intron 23 of WHSC1L1 (MIM: 607083). We used data from two published expression quantitative trait loci (eQTL) data sets (derived from lymphoblastoid cell lines 9,10 and the brain 11 ) to determine whether rs16887244 is associated with expression of the nearby genes. In the expression data from the lymphoblastoid cell lines, rs16887244 is nominally associated with the expression of several genes (ASH2L, LSM1, BAG4, DDHD2 and PPAPDC1B; P < 0.05) (Supplementary Table 6) , and in the expression data from the brain, it is nominally associated with the expression of the ASH2L, DDHD2, PPAPDC1B and LETM2 genes (P < 0.05) (Supplementary Table 7) . These P values were adjusted by PCA methods in the GWAS of each geographical group. l e t t e r s 1 2 2 6 VOLUME 43 | NUMBER 12 | DECEMBER 2011 Nature GeNetics l e t t e r s Notably, rs1488935 is located ~135 kb upstream of FGFR1 (MIM: 136350), encoding the fibroblast growth factor receptor 1 protein.
Hippocampal FGFR1 mRNA expression has been reported to be upregulated in schizophrenia and in individuals with major depression 12 , and transgenic mice expressing a dominant-negative mutant (FGFR1(TK−)) from the catecholaminergic, neuron-specific tyrosine hydroxylase (Th) gene promoter have been found to show a schizophrenia-like syndrome 13 . Several lines of evidence support a role for fibroblast growth factors (FGFs) in schizophrenia, including functional plausibility, positional and functional genetic studies, knockout mouse models, examination of the effects of FGF in animals and humans, and the study of the association between FGFs and environmental risk factors for schizophrenia 14 . Moreover, it has been reported that another FGF receptor gene, FGFR2, is associated with schizophrenia (P = 0.0009) 15 .
On 1q24.2, rs10489202 is located in intron 1 of BRP44, encoding brain protein 44 (Fig. 1b) , rs1060041 is a coding-synonymous SNP in DCAF6 (MIM: 610494) and rs11586522 is located in the intron 2 region of GPR161 (MIM: 612250). Controlling for the most significant signal from rs10489202, logistic regression analysis indicated that there was no additional signal in the genomic region surrounding rs10489202 (Supplementary Table 5 ). In expression data from the lymphoblastoid cell lines, rs10489202 is nominally associated with the expression of several genes (MPZL1, DCAF6 and TIPRL; P < 0.05) (Supplementary Table 6) ; however, in expression data from the brain, no association was observed (Supplementary Table 7 ). Of note, rs10489202 is ~140 kb downstream of MPZL1 (MIM: 604376), which encodes the myelin protein zero-like 1 or protein zero-related. A study found that MPZL1 (PZR) was significantly upregulated in individuals with schizophrenia relative to healthy controls (1.29 fold, P = 0.0263) 16 . Common SNPs in MPZL1 were recently reported to be associated with schizophrenia in a case-parent triad study of 523 subjects in the Han Chinese population (P = 0.0017) 17 .
Population stratification is a major concern in GWAS that use the case-control design. It has been demonstrated using a group of GWAS data sets that there is a "north-south" population structure in China 18 . PCA analysis of all initial study samples also revealed such a structure (Supplementary Figs. 3 and 4) . We therefore stratified our samples into northern, central and southern groups according to their geographic region and carried out GWAS analysis on the individual groups. Combined association results were then obtained using meta-analysis.
The major histocompatibility (MHC) region on 6p21.3-22.1 has previously been associated with schizophrenia in GWAS of individuals of European ancestry [4] [5] [6] , and these findings have been replicated in a large sample of the Han Chinese population 19 . In our initial study, no common SNP in this region met the selection criteria (P GWASs−meta < 5.0 × 10 −6 ). However, 149 SNPs out of 1,786 (8.34%, P GWAS−meta < 0.05) showed nominal association with schizophrenia in the MHC region (Supplementary Table 8) , and the most significant signal was observed at rs2394514 (P GWASs−meta = 1.16 × 10 −5 ), which is located at 6p22.1. We found no significant association for rs13194053 (refs. 4,5) and rs6932590 (ref. 6) on 6p22.1 and rs3131296 (ref. 6) on 6p21.32, which were previously reported to have associations with schizophrenia of genome-wide significance (P < 5.0 × 10 −8 ) in populations of European ancestry (derived from the National Human Genome Research Institute GWAS catalog 20 ; a full listing of SNPs is provided in Supplementary Table 9) . We compared the allele frequencies of these l e t t e r s Tables 11 and  12 ). The rs7749823 SNP, which is in a LD block with rs13194053 (r 2 = 0.644) and rs6932590 (r 2 = 0.623) in populations of European ancestry, showed association with schizophrenia in our study (P GWSs−meta = 4.18 × 10 −5 , A allele OR = 1.64, risk allele frequency (RAF) = 0.97). Haplotype analysis of the HapMap CEU sample showed the frequency of the TTA haplotype at rs13194053, rs6932590 and rs7749823 to be 0.808. As both the T alleles of rs13194053 and rs6932590 are risk alleles for schizophrenia in the European population, our finding of association for the A allele of rs7749823 in the three-marker haplotype in the Han Chinese population is consistent with the findings in individuals of European descent. We also examined other known schizophrenia susceptibility loci (NRGN on 11q24.2 and TCF4 on 18q21.2) that were reported to have genome-wide significance in published studies [4] [5] [6] (Supplementary Table 9 ). None of the SNPs within these loci show association with schizophrenia in our data set. However, genetic heterogeneity obviously exists for schizophrenia risk variants across different ancestries (Supplementary Table 10 ). The presence of this heterogeneity reinforces the need for GWAS of schizophrenia to be carried out in diverse populations.
In summary, we have identified common genetic variants on 8p12 and 1q24.2 that are associated with schizophrenia in the Han Chinese population. Several promising candidate genes are implicated in these two regions, making it difficult to determine precisely which genes contain the causative variants. Nevertheless, the identification of these new common genetic risk variants that predispose individuals to schizophrenia is an encouraging first step in a process that has the potential to translate into improved methods for the prediction and treatment of this disease.
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